GCP Bioanalysis Services

Good Clinical Practice (GCP) compliant bioanalytical laboratory services (UK) supporting human clinical trials in compliance with UK and EU legislation
Intertek's GCP bioanalysis services strive to ensure that Good Clinical Practice (GCP) compliant bioanalytical methods are applied to the analysis of study samples for human clinical trials, as described in the European Medicines Agency (EMA) 2012 Guidance.
GCP is a set of internationally recognized, ethical and scientific quality requirements which must be observed for designing, conducting, recording and reporting clinical trials that involve the participation of human subjects (EU Directive 2001/20/EC, article 1, clause 2). A bioanalytical CRO would require an understanding of the applicable GCPs in order to identify the impact of deviations from a clinical (non-GLP) bioanalytical study or clinical protocol.
Our GCP compliant bioanalytical laboratory conducts human clinical trial sample bioanalysis following the principles of GCP and our staff are fully trained on the GCP expectations associated with clinical sample integrity, respective data integrity and communications, patient safety and confidentially requirements. Our bioanalysis laboratories offer both GCP and Good Laboratory Practice (GLP) bioanalysis contract services to support preclinical and clinical development for a range of product types including small molecule pharmaceuticals, proteins and PEGylated products. GCP bioanalysis services are available across a wide range of bioanalytical technologies, and delivered via our team of experienced Regulatory Project Managers.
Intertek also holds a Human Tissue Licence, regulated and inspected by the Human Tissue Authority (HTA) in the UK, facilitating analytical studies to support our client’s clinical research programs.
GCP Compliant Bioanalytical Services:
- Bioanalytical Technologies
- Bioanalytical method development and validation
- Clinical sample analysis (Human Plasma and Urine)
- Pharmacokinetic (PK) and pharmacodynamic (PD) bioanalysis for small molecules and biologics
- Metals and Inorganic Bioanalysis
- PEGylated drug bioanalysis by NMR
- Non-Standard Bioanalysis Methods
- Stability testing in dose formulations
Related Services:
WHITE PAPER: Best Practice for Pharma Remote Audits
ARTICLE: Biomarker Development & Validation
WHITE PAPER: Strategic Partnerships with Contract Laboratory Organisations
WHITE PAPER: Mitigating Risks in Pharmaceutical Batch Release
WEBINAR: A Hi-Res Accurate Mass Spectrometry Validated Method for Nitrosamine Analysis
WEBINAR: Optimising Protein Impurity Analysis for AAV Capsids
REPORT:Peptide Therapeutics, Designing a Strategic QC Program
ARTICLE:Biophysical Characterisation of Biosimilars
WEBINAR: Glycosylation Site Specific Approaches for Antibody Therapies
WEBINAR: QC Strategy for Vaccine Development
eBOOK: Contingency Outsourcing Solutions
Access our comprehensive Digital Resource Library
RESOURCES
White Paper Downloads:
Bioanalysis Of Pegylated Species In Human Plasma By NMR
Technologies to Measure Immunogenicity
Brochure Downloads:
Trace Metals Bioanalysis and Biomarker Quantification
Bioanalysis Services Brochure